Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study
Holly C. Groom(Kaiser Permanente Center for Health Research), Allison L. Naleway(Centers for Disease Control and Prevention), Matthew F. Daley(Kaiser Permanente), Pradeep Koppolu(Kaiser Permanente Center for Health Research), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), James G. Donahue(Brigham and Women's Hospital), Nicola P. Klein, Ning Smith(Kaiser Permanente Center for Health Research), Elyse O. Kharbanda(HealthPartners), Stephanie A. Irving(Kaiser Permanente Center for Health Research), Natalie McCarthy(Centers for Disease Control and Prevention), Alison Tse Kawai(RTI Health Solutions), James D. Nordin(HealthPartners), Gabriela Vazquez‐Benitez, Lakshmi Sukumaran(Centers for Disease Control and Prevention), Darios Getahun(Kaiser Permanente)
Cited by 42
Related Papers
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602